US Stock MarketDetailed Quotes

PDS Biotechnology (PDSB)

Watchlist
  • 0.9353
  • -0.0094-1.00%
Trading Jan 16 11:27 ET
49.41MMarket Cap-1.15P/E (TTM)

PDS Biotechnology (PDSB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
26.05%-5.92M
-2.75%-9.1M
9.12%-9.03M
-4.14%-35.03M
2.63%-8.23M
-11.48%-8M
-83.99%-8.86M
24.65%-9.94M
-30.83%-33.64M
-12.33%-8.46M
Net income from continuing operations
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
-5.11%-42.94M
43.05%-10.9M
Depreciation and amortization
-0.02%5.46K
0.00%5.46K
15.29%5.46K
21.62%21.11K
15.27%5.46K
15.36%5.46K
15.27%5.46K
50.08%4.74K
20,084.88%17.36K
--4.74K
Other non cash items
-194.51%-297.51K
100.50%1.12M
73.54%485.75K
-21.94%1.46M
-54.84%307.44K
51.17%314.8K
-29.19%560.44K
44.87%279.91K
-65.77%1.87M
-86.87%680.76K
Change In working capital
120.56%1.39M
56.98%-1.24M
-83.16%-2.29M
-2,786.31%-5.75M
-658.83%-2.24M
-54.68%628.44K
-175.72%-2.89M
78.48%-1.25M
-104.45%-199.28K
-92.07%400.69K
-Change in prepaid assets
68.35%80.29K
-316.53%-1.57M
-866.21%-3.4M
-625.31%-870.29K
-1,165.02%-984.79K
-65.67%47.69K
-883.69%-376.4K
489.61%443.21K
115.59%165.67K
-14.91%92.47K
-Change in payables and accrued expense
124.85%1.31M
112.87%323.73K
165.44%1.11M
-3,790.24%-4.88M
-506.97%-1.25M
-55.60%580.75K
-165.15%-2.52M
69.79%-1.69M
-102.08%-125.48K
-93.92%308.23K
-Change in other current liabilities
----
----
----
--0
--0
--0
--0
--0
-222.03%-239.47K
--0
Cash from discontinued investing activities
Operating cash flow
26.05%-5.92M
-2.75%-9.1M
9.12%-9.03M
-4.14%-35.03M
2.63%-8.23M
-11.48%-8M
-83.99%-8.86M
24.65%-9.94M
-30.83%-33.64M
-12.33%-8.46M
Investing cash flow
Cash flow from continuing investing activities
0
-29K
0
-1
0
0
Net PPE purchase and sale
--0
----
----
---29K
--0
---1
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
----
----
---29K
--0
---1
----
----
--0
--0
Financing cash flow
Cash flow from continuing financing activities
1,301.05%241.21K
7,324.31%995.94K
-63.42%7.32M
23.28%20.19M
-98.40%172.78K
-97.85%17.22K
-105.74%-13.79K
338.11%20.01M
-52.24%16.38M
10.92%10.77M
Net issuance payments of debt
-7,099.20%-1.02M
-3,270.96%-464.72K
-23,200.64%-3.14M
-5,263.90%-3.18M
-23,735.92%-3.14M
-9.54%-14.11K
-9.53%-13.79K
34.80%-13.48K
-100.24%-59.3K
---13.17K
Net common stock issuance
1,970.60%1.26M
--1.46M
-62.55%7.3M
40.11%22.6M
-69.77%3.17M
-108.24%-67.18K
--0
324.85%19.49M
63.62%16.13M
6.32%10.48M
Proceeds from stock option exercised by employees
--0
--3.16M
-99.99%71
150.56%774.09K
-51.85%144.5K
--98.5K
--0
--531.09K
104.04%308.94K
146.99%300.09K
Net other financing activities
----
----
--3.16M
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,301.05%241.21K
7,324.31%995.94K
-63.42%7.32M
23.28%20.19M
-98.40%172.78K
-97.85%17.22K
-105.74%-13.79K
338.11%20.01M
-52.24%16.38M
10.92%10.77M
Net cash flow
Beginning cash position
-44.79%31.87M
-40.00%39.98M
-26.29%41.69M
-23.38%56.56M
-8.29%49.75M
-4.77%57.73M
2.20%66.63M
-23.38%56.56M
13.15%73.82M
-24.27%54.25M
Current changes in cash
28.91%-5.67M
8.94%-8.11M
-116.98%-1.71M
13.84%-14.87M
-449.12%-8.06M
-25.24%-7.98M
-94.58%-8.9M
216.86%10.07M
-301.22%-17.26M
6.03%2.31M
End cash Position
-47.34%26.2M
-44.79%31.87M
-40.00%39.98M
-26.29%41.69M
-26.29%41.69M
-8.29%49.75M
-4.77%57.73M
2.20%66.63M
-23.38%56.56M
-23.38%56.56M
Free cash flow
26.05%-5.92M
-2.41%-9.1M
9.12%-9.03M
-4.23%-35.06M
2.63%-8.23M
-11.48%-8M
-84.59%-8.89M
24.65%-9.94M
-30.83%-33.64M
-12.33%-8.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 26.05%-5.92M-2.75%-9.1M9.12%-9.03M-4.14%-35.03M2.63%-8.23M-11.48%-8M-83.99%-8.86M24.65%-9.94M-30.83%-33.64M-12.33%-8.46M
Net income from continuing operations 16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M-5.11%-42.94M43.05%-10.9M
Depreciation and amortization -0.02%5.46K0.00%5.46K15.29%5.46K21.62%21.11K15.27%5.46K15.36%5.46K15.27%5.46K50.08%4.74K20,084.88%17.36K--4.74K
Other non cash items -194.51%-297.51K100.50%1.12M73.54%485.75K-21.94%1.46M-54.84%307.44K51.17%314.8K-29.19%560.44K44.87%279.91K-65.77%1.87M-86.87%680.76K
Change In working capital 120.56%1.39M56.98%-1.24M-83.16%-2.29M-2,786.31%-5.75M-658.83%-2.24M-54.68%628.44K-175.72%-2.89M78.48%-1.25M-104.45%-199.28K-92.07%400.69K
-Change in prepaid assets 68.35%80.29K-316.53%-1.57M-866.21%-3.4M-625.31%-870.29K-1,165.02%-984.79K-65.67%47.69K-883.69%-376.4K489.61%443.21K115.59%165.67K-14.91%92.47K
-Change in payables and accrued expense 124.85%1.31M112.87%323.73K165.44%1.11M-3,790.24%-4.88M-506.97%-1.25M-55.60%580.75K-165.15%-2.52M69.79%-1.69M-102.08%-125.48K-93.92%308.23K
-Change in other current liabilities --------------0--0--0--0--0-222.03%-239.47K--0
Cash from discontinued investing activities
Operating cash flow 26.05%-5.92M-2.75%-9.1M9.12%-9.03M-4.14%-35.03M2.63%-8.23M-11.48%-8M-83.99%-8.86M24.65%-9.94M-30.83%-33.64M-12.33%-8.46M
Investing cash flow
Cash flow from continuing investing activities 0-29K0-100
Net PPE purchase and sale --0-----------29K--0---1----------0--0
Cash from discontinued investing activities
Investing cash flow --0-----------29K--0---1----------0--0
Financing cash flow
Cash flow from continuing financing activities 1,301.05%241.21K7,324.31%995.94K-63.42%7.32M23.28%20.19M-98.40%172.78K-97.85%17.22K-105.74%-13.79K338.11%20.01M-52.24%16.38M10.92%10.77M
Net issuance payments of debt -7,099.20%-1.02M-3,270.96%-464.72K-23,200.64%-3.14M-5,263.90%-3.18M-23,735.92%-3.14M-9.54%-14.11K-9.53%-13.79K34.80%-13.48K-100.24%-59.3K---13.17K
Net common stock issuance 1,970.60%1.26M--1.46M-62.55%7.3M40.11%22.6M-69.77%3.17M-108.24%-67.18K--0324.85%19.49M63.62%16.13M6.32%10.48M
Proceeds from stock option exercised by employees --0--3.16M-99.99%71150.56%774.09K-51.85%144.5K--98.5K--0--531.09K104.04%308.94K146.99%300.09K
Net other financing activities ----------3.16M----------------------------
Cash from discontinued financing activities
Financing cash flow 1,301.05%241.21K7,324.31%995.94K-63.42%7.32M23.28%20.19M-98.40%172.78K-97.85%17.22K-105.74%-13.79K338.11%20.01M-52.24%16.38M10.92%10.77M
Net cash flow
Beginning cash position -44.79%31.87M-40.00%39.98M-26.29%41.69M-23.38%56.56M-8.29%49.75M-4.77%57.73M2.20%66.63M-23.38%56.56M13.15%73.82M-24.27%54.25M
Current changes in cash 28.91%-5.67M8.94%-8.11M-116.98%-1.71M13.84%-14.87M-449.12%-8.06M-25.24%-7.98M-94.58%-8.9M216.86%10.07M-301.22%-17.26M6.03%2.31M
End cash Position -47.34%26.2M-44.79%31.87M-40.00%39.98M-26.29%41.69M-26.29%41.69M-8.29%49.75M-4.77%57.73M2.20%66.63M-23.38%56.56M-23.38%56.56M
Free cash flow 26.05%-5.92M-2.41%-9.1M9.12%-9.03M-4.23%-35.06M2.63%-8.23M-11.48%-8M-84.59%-8.89M24.65%-9.94M-30.83%-33.64M-12.33%-8.46M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More